Gelatin and Bioscience: A Crucial Connection
Despite its valuable properties, however, the use of traditionally manufactured gelatin in biomedicine faces challenges due to the natural potential presence of endotoxins (lipopolysaccharides). Human exposure to endotoxins can trigger immune responses, leading to tissue inflammation, increased sensitivity to other allergens and, in severe cases, fatal shock. As such, in pharmaceutical, medical device and healthcare environments, endotoxin control is crucial to ensure product safety and patient well-being. With MEDELLAPRO® and VACCIPRO®, GELITA offers specialized gelatins and collagen peptides of pharmaceutical grade that are endotoxin-controlled and highly suitable for use in innovative biomedical applications such as 3D bioprinting,medical devices, vaccine stabilization and the production of artificial meat.